CompletedNCT02060162
Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa
Observational studyAges 18–99ZambiaAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 99 years.
- Listed locations
- LusakaSee all locations and recruitment
Study information
Study start dateOctober 2013
- Recruitment status
- Completed
- Enrollment listed in the registry
- 897
- Sponsor
- University of Alabama at Birmingham
- Sponsor type
- University
- Study type
- Observational
- Intervention type
- OTHER
- Study phase
- Not clearly listed
- Locations
- Zambia
- Age range
- From 18 Years to 99 Years
- Official registry ID
- NCT02060162
- Official title
Show the full official title
Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa: a Collaborative Multi-country Prospective Cohort Analysis for International Epidemiologic Databases to Evaluate AIDS- Southern Africa (HIV/HBV-coinfection in IeDEA-SA)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Lusaka
Questions about this study
Who is behind this study?
The study sponsor is University of Alabama at Birmingham, a university.
Who was this study for?
Listed age limits: 18 years to 99 years.
